Merck | MRK - Operating Expenses


Merck reported EUR4.97B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Adidas EUR 6.24B 74M Sep/2026
Adyen EUR 889.68M 94.39M Jun/2026
Akzo Nobel EUR 2.61B 273M Sep/2026
Alcon AG USD 2.78B 370M Jun/2026
Amadeus IT EUR 1.21B 39.6M Sep/2026
Amarin USD 51.48M 113K Dec/2025
AstraZeneca USD 11.55B 674M Sep/2026
BASF EUR 16.49B 719M Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Beiersdorf EUR 4.19B 32M Jun/2026
Covestro EUR 3.24B 5.46B Dec/2025
Danone EUR 12.08B 396M Jun/2026
Fresenius EUR 5.24B 19M Sep/2026
Fresenius Medical Care EUR 4.55B 229.7M Sep/2026
Genmab DKK 748M 77M Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 6.03B 227M Sep/2026
GRIFOLS EUR 1.65B 101M Sep/2026
Henkel EUR 8.7B 35M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Infineon EUR 3.84B 274M Sep/2026
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Linde USD 6.86B 451M Sep/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.97B 630M Sep/2026
Novartis USD 9.88B 325M Sep/2026
Philips EUR 4.23B 478M Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 10.51B 598M Sep/2026
UCB EUR 2.96B 196M Dec/2025